tiprankstipranks
Advertisement
Advertisement
Genprex Expands Reqorsa Cancer Therapy Patent Protection in Israel
PremiumCompany AnnouncementsGenprex Expands Reqorsa Cancer Therapy Patent Protection in Israel
1M ago
Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy
Premium
Company Announcements
Genprex Highlights Promising Preclinical Data for Diabetes Gene Therapy
1M ago
Genprex Expands Lung Cancer Gene Therapy Research Collaboration
Premium
Company Announcements
Genprex Expands Lung Cancer Gene Therapy Research Collaboration
2M ago
Genprex Secures Key Global Patents for REQORSA Therapy
PremiumCompany AnnouncementsGenprex Secures Key Global Patents for REQORSA Therapy
3M ago
Genprex granted Japanese and EU patents for Reqorsa Gene Therapy
Premium
The Fly
Genprex granted Japanese and EU patents for Reqorsa Gene Therapy
3M ago
Genprex Gains Australian Patent Acceptance for REQORSA Therapy
Premium
Company Announcements
Genprex Gains Australian Patent Acceptance for REQORSA Therapy
4M ago
Genprex reports ‘positive’ preclinical data from study of GPX-002
PremiumThe FlyGenprex reports ‘positive’ preclinical data from study of GPX-002
5M ago
Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy
Premium
The Fly
Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy
6M ago
Genprex Announces $75 Million Stock Offering
Premium
Company Announcements
Genprex Announces $75 Million Stock Offering
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100